Ars Pharmaceuticals (SPRY)'s 30-day implied volatility (IV30) was 65.8% at the close on October 29, 2026, down from 73.5% the day before, against a 52-week range of 49.3% to 121.7%. Its 20-day historical volatility was 66.0%.
Data as of October 29, 2026.